Sofinnova Investments, Inc. Ascendis Pharma A/S Transaction History

Sofinnova Investments, Inc.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	SELL	$121.07 - $153.67 $2.39 Million - $3.03 Million	-19,748 Reduced 2.62%	734,284 $100 Million
Q1 2024 Aug 14, 2024	BUY	$123.45 - $159.4 $2.44 Million - $3.15 Million	19,748 Added 2.69%	754,032 $114 Million
Q4 2023 Aug 15, 2024	BUY	$86.1 - $127.36 $1.7 Million - $2.52 Million	19,748 Added 2.69%	754,032 $95 Million
Q1 2023 May 11, 2023	SELL	$104.9 - $126.78 $13.3 Million - $16.1 Million	-126,768 Reduced 14.39%	754,032 $80.8 Million
Q4 2022 Feb 13, 2023	BUY	$99.42 - $131.97 $37.9 Million - $50.3 Million	380,976 Added 76.22%	880,800 $108 Million
Q3 2021 Nov 15, 2021	SELL	$112.67 - $176.92 $2.49 Million - $3.91 Million	-22,099 Reduced 4.23%	499,824 $79.7 Million
Q1 2021 May 14, 2021	SELL	$124.92 - $173.33 $73.4 Million - $102 Million	-587,951 Reduced 52.97%	521,923 $67.3 Million
Q3 2019 Nov 14, 2019	BUY	$95.8 - $118.9 $962,790 - $1.19 Million	10,050 Added 0.91%	1,109,874 $107 Million
Q2 2019 Aug 13, 2019	BUY	$107.11 - $132.09 $10.8 Million - $13.4 Million	101,286 Added 10.14%	1,099,824 $127 Million
Q1 2019 May 15, 2019	SELL	$62.15 - $129.99 $31.1 Million - $65 Million	-500,000 Reduced 33.37%	998,538 $118 Million
Q4 2018 Feb 14, 2019	SELL	$55.16 - $69.67 $54.1 Million - $68.3 Million	-980,976 Reduced 39.56%	1,498,538 $93.9 Million
Q1 2018 May 15, 2018	BUY	$38.98 - $68.04 $96.7 Million - $169 Million	2,479,514 New	2,479,514 $162 Million

244

58.8M

250K

377K

Ticker ASND
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,810,200
Market Cap $7.61B
Description
Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...

Get notified when there are updates to the investment portfolio of Sofinnova Investments, Inc., based on Form 13F filings with the SEC.

Stay updated on Sofinnova Investments, Inc. with notifications on news.